Canlyniadau Chwilio - Bernhard Scheiner

Mireinio'r Canlyniadau
  1. 1
    Immunotherapy for advanced hepatocellular carcinoma: a focus on special subgroups

    Immunotherapy for advanced hepatocellular carcinoma: a focus on special subgroups gan Matthias Pinter, Bernhard Scheiner, Markus Peck‐Radosavljevic

    Cyhoeddwyd 2020
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  2. 2
    Acid-base disorders in liver disease

    Acid-base disorders in liver disease gan Bernhard Scheiner, Gregor Lindner, Thomas Reiberger, Bruno Schneeweiß, Michael Trauner, Christian Zauner, Georg‐Christian Funk

    Cyhoeddwyd 2017
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  3. 3
    Use of the CytoSorb adsorber in patients with acute-on-chronic liver failure

    Use of the CytoSorb adsorber in patients with acute-on-chronic liver failure gan Patrick Haselwanter, Bernhard Scheiner, Lorenz Balcar, Georg Semmler, Marlene Riedl-Wewalka, Monika Schmid, Thomas Reiberger, Christian Zauner, Mathias Schneeweiss‐Gleixner

    Cyhoeddwyd 2024
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  4. 4
    Efficacy and Safety of Atezolizumab and Bevacizumab in the Real-World Treatment of Advanced Hepatocellular Carcinoma: Experience from Four Tertiary Centers

    Efficacy and Safety of Atezolizumab and Bevacizumab in the Real-World Treatment of Advanced Hepatocellular Carcinoma: Experience from Four Tertiary Centers gan Vera Himmelsbach, Matthias Pinter, Bernhard Scheiner, Marino Venerito, Friedrich Sinner, Carolin Zimpel, Jens U. Marquardt, Jörg Trojan, Oliver Waidmann, Fabian Finkelmeier

    Cyhoeddwyd 2022
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  5. 5
    Prevalence of and risk factors for anaemia in patients with advanced chronic liver disease

    Prevalence of and risk factors for anaemia in patients with advanced chronic liver disease gan Bernhard Scheiner, Georg Semmler, Florian P. Maurer, Philipp Schwabl, Theresa Bucsics, Rafael Paternostro, David Bauer, Benedikt Simbrunner, Michael Trauner, Mattias Mandorfer, Thomas Reiberger

    Cyhoeddwyd 2019
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  6. 6
    Dysregulated biomarkers of innate and adaptive immunity predict infections and disease progression in cirrhosis

    Dysregulated biomarkers of innate and adaptive immunity predict infections and disease progression in cirrhosis gan Benedikt Simbrunner, Lukas Hartl, Mathias Jachs, David Bauer, Bernhard Scheiner, Benedikt Hofer, Albert Friedrich Stättermayer, Rodrig Marculescu, Michael Trauner, Mattias Mandorfer, Thomas Reiberger

    Cyhoeddwyd 2023
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  7. 7
    Hepatic recompensation according to Baveno <scp>VII</scp> criteria is linked to a significant survival benefit in decompensated alcohol‐related cirrhosis

    Hepatic recompensation according to Baveno <scp>VII</scp> criteria is linked to a significant survival benefit in decompensated alcohol‐related cirrhosis gan Benedikt Hofer, Benedikt Simbrunner, Lukas Hartl, Mathias Jachs, Lorenz Balcar, Rafael Paternostro, Philipp Schwabl, Georg Semmler, Bernhard Scheiner, Michael Trauner, Mattias Mandorfer, Thomas Reiberger

    Cyhoeddwyd 2023
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  8. 8
    Bacterial translocation occurs early in cirrhosis and triggers a selective inflammatory response

    Bacterial translocation occurs early in cirrhosis and triggers a selective inflammatory response gan Benedikt Simbrunner, Esther Caparrós, Teresa Neuwirth, Philipp Schwabl, Philipp Königshofer, David Bauer, Rodrig Marculescu, Michael Trauner, Bernhard Scheiner, Georg Stary, Mattias Mandorfer, Thomas Reiberger, Rubén Francés

    Cyhoeddwyd 2023
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  9. 9
    Systemic inflammation increases across distinct stages of advanced chronic liver disease and correlates with decompensation and mortality

    Systemic inflammation increases across distinct stages of advanced chronic liver disease and correlates with decompensation and mortality gan Dalila Costa, Benedikt Simbrunner, Mathias Jachs, Lukas Hartl, David Bauer, Rafael Paternostro, Philipp Schwabl, Bernhard Scheiner, Albert Friedrich Stättermayer, Matthias Pinter, Michael Trauner, Mattias Mandorfer, Thomas Reiberger

    Cyhoeddwyd 2020
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  10. 10
    Study protocol: Fecal Microbiota Transplant combined with Atezolizumab/Bevacizumab in Patients with Hepatocellular Carcinoma who failed to achieve or maintain objective response to Atezolizumab/Bevacizumab – the FAB-HCC pilot study

    Study protocol: Fecal Microbiota Transplant combined with Atezolizumab/Bevacizumab in Patients with Hepatocellular Carcinoma who failed to achieve or maintain objective response to... gan Katharina Pomej, Adrian Frick, Bernhard Scheiner, Lorenz Balcar, Larissa Pajancic, Anton Klotz, Alexander Kreuter, Katharina Lampichler, Katharina Regnat, Kerstin Zinober, Michael Trauner, Dietmar Tamandl, Christoph Gasché, Matthias Pinter

    Cyhoeddwyd 2025
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  11. 11
    Anticoagulation in non-malignant portal vein thrombosis is safe and improves hepatic function

    Anticoagulation in non-malignant portal vein thrombosis is safe and improves hepatic function gan Bernhard Scheiner, Paul René Stammet, S Pokorný, Theresa Bucsics, Philipp Schwabl, A. Brichta, J. Thaler, Katharina Lampichler, Ahmed Ba-Ssalamah, Cihan Ay, Arnulf Ferlitsch, Michael Trauner, Mattias Mandorfer, Thomas Reiberger

    Cyhoeddwyd 2018
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  12. 12
    Association of Platelet Count and Mean Platelet Volume with Overall Survival in Patients with Cirrhosis and Unresectable Hepatocellular Carcinoma

    Association of Platelet Count and Mean Platelet Volume with Overall Survival in Patients with Cirrhosis and Unresectable Hepatocellular Carcinoma gan Bernhard Scheiner, Martha M. Kirstein, Sabine Popp, Florian Hucke, Simona Bota, Nataliya Rohr‐Udilova, Thomas Reiberger, Christian Müller, Michael Trauner, Markus Peck‐Radosavljevic, Arndt Vogel, Wolfgang Sieghart, Matthias Pinter

    Cyhoeddwyd 2018
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  13. 13
    Decreasing von Willebrand Factor Levels Upon Nonselective Beta Blocker Therapy Indicate a Decreased Risk of Further Decompensation, Acute-on-chronic Liver Failure, and Death

    Decreasing von Willebrand Factor Levels Upon Nonselective Beta Blocker Therapy Indicate a Decreased Risk of Further Decompensation, Acute-on-chronic Liver Failure, and Death gan Mathias Jachs, Lukas Hartl, Benedikt Simbrunner, David Bauer, Rafael Paternostro, Bernhard Scheiner, Philipp Schwabl, Albert Friedrich Stättermayer, Matthias Pinter, Ernst Eigenbauer, Peter Quehenberger, Michael Trauner, Thomas Reiberger, Mattias Mandorfer

    Cyhoeddwyd 2021
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  14. 14
    The Sequential Application of Baveno VII Criteria and VITRO Score Improves Diagnosis of Clinically Significant Portal Hypertension

    The Sequential Application of Baveno VII Criteria and VITRO Score Improves Diagnosis of Clinically Significant Portal Hypertension gan Mathias Jachs, Lukas Hartl, Benedikt Simbrunner, David Bauer, Rafael Paternostro, Bernhard Scheiner, Lorenz Balcar, Georg Semmler, Albert Friedrich Stättermayer, Matthias Pinter, Peter Quehenberger, Michael Trauner, Thomas Reiberger, Mattias Mandorfer

    Cyhoeddwyd 2022
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  15. 15
    Interferon‐free regimens improve portal hypertension and histological necroinflammation in <scp>HIV</scp>/<scp>HCV</scp> patients with advanced liver disease

    Interferon‐free regimens improve portal hypertension and histological necroinflammation in <scp>HIV</scp>/<scp>HCV</scp> patients with advanced liver disease gan Philipp Schwabl, Mattias Mandorfer, Sabine Steiner, Bernhard Scheiner, David Chromy, Merima Herac, Theresa Bucsics, Hubert Hayden, Katharina Grabmeier‐Pfistershammer, Arnulf Ferlitsch, Georg Oberhuber, Michael Trauner, Markus Peck‐Radosavljevic, Thomas Reiberger

    Cyhoeddwyd 2016
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  16. 16
    Safety of direct oral anticoagulants in patients with advanced liver disease

    Safety of direct oral anticoagulants in patients with advanced liver disease gan Georg Semmler, Katharina Pomej, David Bauer, Lorenz Balcar, Benedikt Simbrunner, Teresa Binter, Lukas Hartl, Jeannette Becker, Matthias Pinter, Peter Quehenberger, Michael Trauner, Mattias Mandorfer, Ton Lisman, Thomas Reiberger, Bernhard Scheiner

    Cyhoeddwyd 2021
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  17. 17
    Novel reliability criteria for controlled attenuation parameter assessments for non‐invasive evaluation of hepatic steatosis

    Novel reliability criteria for controlled attenuation parameter assessments for non‐invasive evaluation of hepatic steatosis gan Georg Semmler, Katharina Wöran, Bernhard Scheiner, Lukas Unger, Rafael Paternostro, Judith Stift, Philipp Schwabl, Theresa Bucsics, David Bauer, Benedikt Simbrunner, Albert Friedrich Stättermayer, Matthias Pinter, Michael Trauner, Thomas Reiberger, Mattias Mandorfer

    Cyhoeddwyd 2020
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  18. 18
    Carvedilol Achieves Higher Hemodynamic Response and Lower Rebleeding Rates Than Propranolol in Secondary Prophylaxis

    Carvedilol Achieves Higher Hemodynamic Response and Lower Rebleeding Rates Than Propranolol in Secondary Prophylaxis gan Mathias Jachs, Lukas Hartl, Benedikt Simbrunner, David Bauer, Rafael Paternostro, Lorenz Balcar, Benedikt Hofer, Nikolaus Pfisterer, Michael Schwarz, Bernhard Scheiner, Albert Friedrich Stättermayer, Matthias Pinter, Michael Trauner, Mattias Mandorfer, Thomas Reiberger

    Cyhoeddwyd 2022
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  19. 19
    Impact of ammonia levels on outcome in clinically stable outpatients with advanced chronic liver disease

    Impact of ammonia levels on outcome in clinically stable outpatients with advanced chronic liver disease gan Lorenz Balcar, Julia Krawanja, Bernhard Scheiner, Rafael Paternostro, Benedikt Simbrunner, Georg Semmler, Mathias Jachs, Lukas Hartl, Albert Friedrich Stättermayer, Philipp Schwabl, Matthias Pinter, Thomas Szekeres, Michael Trauner, Thomas Reiberger, Mattias Mandorfer

    Cyhoeddwyd 2023
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  20. 20
    Efficacy and safety of frontline systemic therapy for advanced HCC: A network meta-analysis of landmark phase III trials

    Efficacy and safety of frontline systemic therapy for advanced HCC: A network meta-analysis of landmark phase III trials gan Claudia Angela Maria Fulgenzi, Bernhard Scheiner, James Korolewicz, Charalampos‐Vlasios Stikas, Alessandra Gennari, Bruno Vincenzi, Mark R. Openshaw, Marianna Silletta, Matthias Pinter, Alessio Cortellini, Lorenza Scotti, Antonio D’Alessio, David J. Pinato

    Cyhoeddwyd 2023
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:

Offerynnau Chwilio: